Diagnostic procedures (64 cases, 100%):

・ Incisional biopsy

・ Tru-cut needle biopsy

・ Excisional biopsy

・ Frozen section analysis

・ FNAC

28 (43.7%)

16 (25%)

6 (9.4%)

10 (15.6%)

4 (6.2%)

Surgical procedures (64 cases, 100%):

・ MRM

・ RM

・ Simple (total) mastectomy

・ Only biopsy

・ Surgery refusal

26 (40.6%)

18 (28.1%)

6 (9.3%)

10 (15.6%)

4 (6.2%)

Types of reconstruction (50 cases, 100%):

・ Primary closure

・ Local flap

・ LD myocutaneus flap

・ Double layer proline mesh & RA myocutaneus flap

34 (68%)

8 (16%)

6 (12%)

2 (4%)

Postoperative complications:

(More than one complication may be present in the same patient)

・ Seroma

・ Partial edge sloughing of the flap

・ Wound infection

・ Acute liver failure

18 (36%)

6 (12%)

2 (4%)

Non surgical management:

1) Hormonal therapy (64 cases, 100%):

・ Adjuvant

・ Palliative

2) Chemotherapy (32 cases, 100%):

・ Adjuvant

・ Palliative

3) Radiation therapy (26 cases, 100%):

・ Adjuvant

・ Palliative

36 (56.2%)

28 (43.8%)

24 (75%)

8 (25%)

20 (76.9%)

6 (23.1%)

Chemotherapeutic agents (32 cases, 100%):

・ CMF (cyclophosphamide, methotrexate & 5-flurouracil)

・ CAF (cyclophosphamide, adriamycin & 5-flurouracil)

・ Taxnes (taxol) & FEC

・ FEC (5-flurouracil, endoxan, cyclophosphamide)

19 (59.3%)

8 (25%)

3 (9.3)

2 (6.3%)